Disparity in hematological malignancies: From patients to health care professionals

IF 6.9 2区 医学 Q1 HEMATOLOGY Blood Reviews Pub Date : 2024-01-08 DOI:10.1016/j.blre.2024.101169
Xiaoyi Chen , Mihir Shukla , Shella Saint Fleur-Lominy
{"title":"Disparity in hematological malignancies: From patients to health care professionals","authors":"Xiaoyi Chen ,&nbsp;Mihir Shukla ,&nbsp;Shella Saint Fleur-Lominy","doi":"10.1016/j.blre.2024.101169","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>In the recent few decades, outcomes in patients diagnosed with </span>hematological malignancies<span> have been steadily improving. However, the improved prognosis does not distribute equally among patients from different backgrounds. Besides cancer biology, demographic and geographic disparities have been found to impact </span></span>overall survival<span> significantly. Specifically, patients from underrepresented minorities including Black and Hispanics, and those with uninsured status, having low socioeconomic status, or from rural areas have had worse outcomes historically, which is uniformly true across all major subtypes of hematological malignancies. Similar discrepancy is also seen in the health care professional field, where a gender gap and a disproportionally low representation of health care providers from underrepresented minorities have been long existing. Thus, a comprehensive strategy to mitigate disparity in the health care system is needed to achieve equity in health care.</span></p></div>","PeriodicalId":56139,"journal":{"name":"Blood Reviews","volume":null,"pages":null},"PeriodicalIF":6.9000,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0268960X2400002X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In the recent few decades, outcomes in patients diagnosed with hematological malignancies have been steadily improving. However, the improved prognosis does not distribute equally among patients from different backgrounds. Besides cancer biology, demographic and geographic disparities have been found to impact overall survival significantly. Specifically, patients from underrepresented minorities including Black and Hispanics, and those with uninsured status, having low socioeconomic status, or from rural areas have had worse outcomes historically, which is uniformly true across all major subtypes of hematological malignancies. Similar discrepancy is also seen in the health care professional field, where a gender gap and a disproportionally low representation of health care providers from underrepresented minorities have been long existing. Thus, a comprehensive strategy to mitigate disparity in the health care system is needed to achieve equity in health care.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血液恶性肿瘤的差异:从患者到医护人员
近几十年来,血液恶性肿瘤患者的预后一直在稳步改善。然而,预后的改善并没有在不同背景的患者中平等分配。除了癌症生物学因素外,人口和地域差异也对总生存率产生了重大影响。具体来说,包括黑人和西班牙裔在内的代表性不足的少数族裔患者,以及无保险、社会经济地位低下或来自农村地区的患者,其预后历来较差,这在血液恶性肿瘤的所有主要亚型中都是一致的。在医疗保健专业领域也存在类似的差异,长期以来一直存在着性别差距,以及来自代表人数不足的少数族裔的医疗保健提供者比例过低的问题。因此,要实现医疗保健的公平性,亟需采取综合战略来缩小医疗保健系统中的差距。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Blood Reviews
Blood Reviews 医学-血液学
CiteScore
13.80
自引率
1.40%
发文量
78
期刊介绍: Blood Reviews, a highly regarded international journal, serves as a vital information hub, offering comprehensive evaluations of clinical practices and research insights from esteemed experts. Specially commissioned, peer-reviewed articles authored by leading researchers and practitioners ensure extensive global coverage across all sub-specialties of hematology.
期刊最新文献
Corrigendum to "Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways?"[BLOOD REVIEWS, 9 August 2024, https://doi.org/10.1016/j.blre.2024.101226]. Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH. Ven the dose matters: Venetoclax dosing in the frontline treatment of AML. Editorial Board Addressing the surge of infections by multidrug-resistant Enterobacterales in hematopoietic cell transplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1